Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OR › Medford › NPI 1770587107
Hospital

Asante

Asante was paid $29.67M by Medicaid between Jan 2018 and Dec 2024, across 173 billing codes. Its largest line is 99284, emergency room visit (serious) — 32% of everything it billed.

33Billing provider infoASANTE
MEDFORD, OR 97504
33aNPI1770587107assigned 06/13/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$29.67M
24GClaims681,755
24DCodes billed173
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Oregon

Rank by total paid#4 of 17
Median peer was paid$13.35M
This provider vs. median2.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201891,534$3.54M
201996,906$3.71M
202076,109$3.69M
2021104,113$4.15M
2022119,533$4.91M
2023110,405$4.91M
2024incomplete83,155$4.76M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 32% 43,395 36,874 $9.37M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 27% 53,507 46,427 $8.03M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 7.8% 37,475 22,153 $2.31M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.7% 10,218 8,782 $2.28M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3.9% 29,015 19,983 $1.16M
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 2.7% 4,373 4,180 $794K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.5% 6,115 5,455 $756K
76819 Fetal biophysical profile; without non-stress testing 2.1% 6,717 3,913 $624K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.7% 4,824 4,490 $498K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 1.5% 7,986 7,298 $447K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 1.0% 3,311 3,172 $304K
80053 Comprehensive metabolic panel <1% 96,763 86,845 $257K
161 more codes
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 13,807 $249K
84443 Thyroid stimulating hormone (TSH) <1% 20,830 $211K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 99,146 $176K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,353 $167K
86900 <1% 2,467 $166K
80061 Lipid panel <1% 19,774 $156K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,688 $149K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 7,861 $148K
76813 <1% 1,505 $139K
71046 Radiologic examination, chest; 2 views <1% 2,557 $136K
36415 Collection of venous blood by venipuncture <1% 86,895 $116K
83036 Hemoglobin; glycosylated (A1C) <1% 17,069 $92K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 489 $86K
93296 <1% 4,458 $58K
76825 <1% 115 $53K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 3,028 $50K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 584 $43K
80074 <1% 1,159 $40K
96375 Therapeutic injection; each additional sequential IV push <1% 996 $37K
86780 <1% 3,379 $31K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 1,111 $30K
43762 <1% 272 $30K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,983 $30K
97602 <1% 468 $26K
84439 <1% 4,058 $24K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 920 $23K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 912 $23K
71045 Radiologic examination, chest; single view <1% 469 $23K
96361 Intravenous infusion, hydration; each additional hour <1% 584 $18K
29581 <1% 303 $17K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 39 $16K
76801 <1% 162 $15K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,799 $15K
87631 <1% 402 $14K
81514 <1% 59 $12K
99214 Doctor's office visit, returning patient (more involved) <1% 713 $11K
97597 <1% 207 $10K
0240U <1% 118 $10K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 39 $9K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 74 $8K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 946 $8K
84207 <1% 442 $8K
82607 <1% 786 $8K
70450 Computed tomography, head or brain; without contrast material <1% 76 $8K
82746 <1% 752 $7K
87081 <1% 1,476 $7K
87536 <1% 151 $7K
43235 <1% 12 $7K
87150 <1% 239 $6K
82728 <1% 667 $6K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 1,365 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 135 $5K
84481 <1% 441 $5K
J3490 Unclassified drugs <1% 342 $5K
99201 <1% 52 $4K
85027 <1% 2,122 $4K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 7,481 $4K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 43 $4K
99070 <1% 260 $3K
86762 <1% 334 $3K
83721 <1% 469 $3K
83550 <1% 490 $3K
82043 <1% 809 $2K
87340 <1% 333 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 533 $2K
82670 <1% 112 $2K
82570 <1% 855 $2K
87800 <1% 70 $2K
84480 <1% 264 $2K
93298 <1% 95 $2K
83540 <1% 502 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 52 $2K
85007 <1% 1,875 $2K
95806 <1% 13 $2K
86360 <1% 79 $2K
82950 <1% 462 $2K
86359 <1% 79 $1K
86141 <1% 145 $1K
86850 <1% 2,386 $1K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 214 $1K
83880 <1% 87 $1K
94010 <1% 12 $1K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 260 $1K
84403 <1% 54 $1K
84402 <1% 53 $951.40
81003 <1% 954 $948.23
80069 <1% 261 $932.89
84144 <1% 59 $904.98
86803 <1% 96 $872.11
81001 <1% 7,010 $851.46
93295 <1% 112 $762.28
83090 <1% 65 $748.37
84252 <1% 54 $741.32
82627 <1% 39 $638.66
95251 <1% 34 $615.73
84425 <1% 39 $534.76
0450 Emergency room services <1% 15 $496.00
82533 <1% 41 $495.52
93294 <1% 122 $492.43
80048 Basic metabolic panel (calcium, ionized) <1% 282 $435.61
86140 <1% 101 $369.03
82550 <1% 92 $304.47
86901 <1% 2,469 $265.54
99213 Doctor's office visit, returning patient (routine) <1% 158 $253.13
83525 <1% 30 $212.12
83615 <1% 231 $204.63
85610 <1% 6,831 $189.81
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 39 $185.08
82274 <1% 12 $152.88
84154 <1% 15 $141.00
84153 <1% 15 $141.00
87070 <1% 15 $94.86
87077 <1% 14 $83.99
85018 <1% 38 $66.73
81015 <1% 29 $65.58
87641 <1% 13 $56.14
87205 <1% 15 $50.01
85045 <1% 12 $38.28
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 110 $29.72
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 564 $29.43
83690 <1% 1,620 $11.47
85652 <1% 13 $9.20
84703 <1% 1,415 $6.39
17250 <1% 40 $2.17
A6212 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing 0% 7,344 $0.00
J2405 Injection, ondansetron hydrochloride, per 1 mg 0% 156 $0.00
A6021 Collagen dressing, sterile, size 16 sq. in. or less, each 0% 386 $0.00
A6196 Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing 0% 2,436 $0.00
A6251 Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing 0% 1,199 $0.00
A6457 Tubular dressing with or without elastic, any width, per linear yard 0% 328 $0.00
A6266 Gauze, impregnated, other than water, normal saline, or zinc paste, sterile, any width, per linear yard 0% 1,039 $0.00
76821 0% 351 $0.00
A6209 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing 0% 178 $0.00
93325 0% 117 $0.00
A6206 Contact layer, sterile, 16 sq. in. or less, each dressing 0% 168 $0.00
76827 0% 114 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 0% 13 $0.00
76000 0% 13 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 18 $0.00
84484 0% 1,112 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 0% 418 $0.00
A6452 High compression bandage, elastic, knitted/woven, load resistance greater than or equal to 1.35 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard 0% 303 $0.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 0% 59 $0.00
A6456 Zinc paste impregnated bandage, non-elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard 0% 47 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 347 $0.00
A6213 Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing 0% 353 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 0% 163 $0.00
J2704 Injection, propofol, 10 mg 0% 401 $0.00
85730 0% 482 $0.00
A6252 Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing 0% 65 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 65 $0.00
A6454 Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard 0% 645 $0.00
A6207 Contact layer, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing 0% 662 $0.00
88305 Level IV - Surgical pathology, gross and microscopic examination 0% 338 $0.00
A6240 Hydrocolloid dressing, wound filler, paste, sterile, per ounce 0% 82 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 76 $0.00
G0378 Hospital observation service, per hour 0% 31 $0.00
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 0% 30 $0.00
76820 0% 132 $0.00
83735 0% 22 $0.00
82962 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROWENHORST, HEATHER (CHIEF FINANCE OFFICER)
Same official

Other billing entities under ROWENHORST, HEATHER

Full network →
ProviderLocationPaid
Asante Three Rivers Medical Center, LLCGrants Pass, OR$27.57M
Asante Ashland Community Hospital, LLCAshland, OR$8.99M
AsanteMedford, OR$5.34M
Asante Three Rivers Medical Center LLCGrants Pass, OR$5.17M
Asante Community Services LLCMedford, OR$938K
Asante Three Rivers Medical Center, LLCGrants Pass, OR$64K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.